Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 40% ± 18% | |
lung | 11 studies | 31% ± 14% | |
eye | 8 studies | 27% ± 17% | |
heart | 5 studies | 33% ± 11% | |
placenta | 4 studies | 29% ± 13% | |
prostate | 4 studies | 27% ± 7% | |
intestine | 4 studies | 20% ± 2% | |
kidney | 4 studies | 31% ± 9% | |
peripheral blood | 3 studies | 25% ± 3% | |
uterus | 3 studies | 32% ± 19% | |
breast | 3 studies | 24% ± 6% | |
liver | 3 studies | 36% ± 16% | |
adipose | 3 studies | 46% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 9084.15 | 1445 / 1445 | 100% | 84.27 | 183 / 183 |
ovary | 100% | 8511.31 | 180 / 180 | 100% | 121.07 | 430 / 430 |
prostate | 100% | 7438.62 | 245 / 245 | 100% | 91.16 | 502 / 502 |
breast | 100% | 9120.61 | 459 / 459 | 100% | 125.34 | 1116 / 1118 |
brain | 100% | 7436.84 | 2640 / 2642 | 100% | 133.46 | 704 / 705 |
kidney | 100% | 8290.22 | 89 / 89 | 100% | 81.42 | 898 / 901 |
skin | 100% | 8114.31 | 1809 / 1809 | 100% | 100.26 | 470 / 472 |
lung | 100% | 9689.87 | 578 / 578 | 100% | 97.87 | 1150 / 1155 |
adrenal gland | 100% | 15932.15 | 258 / 258 | 100% | 84.29 | 229 / 230 |
uterus | 100% | 9245.23 | 170 / 170 | 100% | 88.92 | 457 / 459 |
pancreas | 100% | 6349.74 | 328 / 328 | 99% | 96.11 | 177 / 178 |
bladder | 100% | 7247.10 | 21 / 21 | 99% | 74.58 | 501 / 504 |
thymus | 100% | 8295.41 | 653 / 653 | 99% | 94.70 | 601 / 605 |
stomach | 100% | 6507.06 | 359 / 359 | 99% | 57.64 | 284 / 286 |
intestine | 100% | 8491.04 | 966 / 966 | 99% | 61.35 | 522 / 527 |
liver | 100% | 3638.78 | 226 / 226 | 95% | 45.12 | 387 / 406 |
adipose | 100% | 9131.57 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 13833.27 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 44.52 | 29 / 29 |
muscle | 100% | 10067.62 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6246.99 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 56.85 | 1 / 1 |
peripheral blood | 100% | 8688.57 | 928 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 7278.01 | 842 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 61.40 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 96% | 54.64 | 77 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0070979 | Biological process | protein K11-linked ubiquitination |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0061631 | Molecular function | ubiquitin conjugating enzyme activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | UBE2H |
Protein name | Ubiquitin conjugating enzyme E2 H Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (UbcH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H) Uncharacterized protein UBE2H E2 ubiquitin-conjugating enzyme (EC 2.3.2.23) Ubiquitin conjugating enzyme E2 H (Ubiquitin-conjugating enzyme E2H (UBC8 homolog, yeast), isoform CRA_a) |
Synonyms | hCG_18056 tcag7.352 |
Description | FUNCTION: Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins . E2 ubiquitin conjugating enzyme that transfers ubiquitin to MAEA, a core component of the CTLH E3 ubiquitin-protein ligase complex . In vitro catalyzes 'Lys-11'- and 'Lys-48'-linked polyubiquitination . Capable, in vitro, to ubiquitinate histone H2A . . |
Accessions | A4D1L5 A0A3B3IU20 C9JZY6 ENST00000649897.1 ENST00000496698.5 ENST00000472396.5 ENST00000490974.1 P62256 C9JZG9 H7C4M9 ENST00000355621.8 [P62256-1] C9J8Q9 Q75MF5 ENST00000480245.5 ENST00000473814.6 [P62256-2] |